206 related articles for article (PubMed ID: 6418368)
1. Short-course chemotherapy for mycobacteriosis kansasii?
Schraufnagel DE; Leech JA; Schraufnagel MN; Pollak B
Can Med Assoc J; 1984 Jan; 130(1):34-8. PubMed ID: 6418368
[TBL] [Abstract][Full Text] [Related]
2. Rifampin-resistant Mycobacterium kansasii.
Wallace RJ; Dunbar D; Brown BA; Onyi G; Dunlap R; Ahn CH; Murphy DT
Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
[TBL] [Abstract][Full Text] [Related]
3. [Acquired rifampicin resistance during M. kansasii infection in a patient with AIDS].
Dautzenberg B; Antoun F; Truffot C
Rev Mal Respir; 1992; 9(4):464-6. PubMed ID: 1509191
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary
Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs.
Ahn CH; Lowell JR; Ahn SS; Ahn S; Hurst GA
Rev Infect Dis; 1981; 3(5):1028-34. PubMed ID: 7339800
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii.
Ahn CH; Wallace RJ; Steele LC; Murphy DT
Am Rev Respir Dis; 1987 Jan; 135(1):10-6. PubMed ID: 3800137
[TBL] [Abstract][Full Text] [Related]
7. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary mycobacteriosis in personal clinical material].
Krasucka-Kluźniak A; Krakówka P
Pneumonol Alergol Pol; 1995; 63(7-8):393-401. PubMed ID: 8520556
[TBL] [Abstract][Full Text] [Related]
10. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary disease due to Mycobacterium massiliense.
Mitra S; Tapadar SR; Banerjee D; Bhattacharjee S; Dey S; Kundu S
Indian J Chest Dis Allied Sci; 2012; 54(1):53-7. PubMed ID: 22779125
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the nontuberculous lung mycobacteriosis in Japan. (Report of the study in the year 1987 and 1988 of the Mycobacteriosis Research Group of the Japanese National Chest Hospitals)--pulmonary infection caused by Mycobacterium kansasii has begun to appear in all over Japan including north Japan Hokkaido].
Kita N; Tsukamura M; Kuze A; Shinoda A; Kurashima A; Wada R; Kawahara S; Kimura C; Motoki T; Miyazaki N
Kekkaku; 1991 Oct; 66(10):651-9. PubMed ID: 1960913
[TBL] [Abstract][Full Text] [Related]
14. Management of disease due to Mycobacterium kansasii.
Griffith DE
Clin Chest Med; 2002 Sep; 23(3):613-21, vi. PubMed ID: 12370997
[TBL] [Abstract][Full Text] [Related]
15. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin.
Pezzia W; Raleigh JW; Bailey MC; Toth EA; Silverblatt J
Rev Infect Dis; 1981; 3(5):1035-9. PubMed ID: 7339801
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis due to Mycobacterium kansasii.
Elder JL; Edwards FG; Abrahams EW
Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary mycobacteriosis caused by Mycobacterium peregrinum in a young, healthy man].
Sawahata M; Hagiwara E; Ogura T; Komatsu S; Sekine A; Tsuchiya N; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):866-70. PubMed ID: 21141068
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
Rowińska-Zakrzewska E; Słupek A; Graczyk J; Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Stambrowska A; Byszewska D; Latoś E; Pilarska A; Andrzejczyk Z
Pneumonol Alergol Pol; 1992; 60(9-10):81-8. PubMed ID: 1338003
[No Abstract] [Full Text] [Related]
20. [Pulmonary infection due to Mycobacterium szulgai, a group 2 nontuberculous mycobacterium].
Nyui M; Katura T; Tanaka K; Yoshida H
Nihon Kokyuki Gakkai Zasshi; 2001 Dec; 39(12):920-3. PubMed ID: 11875808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
